These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11506399)

  • 1. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage.
    Werner P; Pitt D; Raine CS
    Ann Neurol; 2001 Aug; 50(2):169-80. PubMed ID: 11506399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
    Werner P; Pitt D; Raine CS
    J Neural Transm Suppl; 2000; (60):375-85. PubMed ID: 11205156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.
    Pitt D; Nagelmeier IE; Wilson HC; Raine CS
    Neurology; 2003 Oct; 61(8):1113-20. PubMed ID: 14581674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor expression in multiple sclerosis lesions.
    Newcombe J; Uddin A; Dove R; Patel B; Turski L; Nishizawa Y; Smith T
    Brain Pathol; 2008 Jan; 18(1):52-61. PubMed ID: 17924980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
    Azami Tameh A; Clarner T; Beyer C; Atlasi MA; Hassanzadeh G; Naderian H
    Ann Anat; 2013 Oct; 195(5):415-23. PubMed ID: 23711509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
    Mews I; Bergmann M; Bunkowski S; Gullotta F; Brück W
    Mult Scler; 1998 Apr; 4(2):55-62. PubMed ID: 9599334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology.
    Bonetti B; Stegagno C; Cannella B; Rizzuto N; Moretto G; Raine CS
    Am J Pathol; 1999 Nov; 155(5):1433-8. PubMed ID: 10550297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.
    Cambron M; D'Haeseleer M; Laureys G; Clinckers R; Debruyne J; De Keyser J
    J Cereb Blood Flow Metab; 2012 Mar; 32(3):413-24. PubMed ID: 22214904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Golli proteins in adult human brain and multiple sclerosis lesions.
    Filipovic R; Rakic S; Zecevic N
    J Neuroimmunol; 2002 Jun; 127(1-2):1-12. PubMed ID: 12044969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity.
    Takahashi JL; Giuliani F; Power C; Imai Y; Yong VW
    Ann Neurol; 2003 May; 53(5):588-95. PubMed ID: 12730992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate and ATP signalling in white matter pathology.
    Matute C
    J Anat; 2011 Jul; 219(1):53-64. PubMed ID: 21250988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
    Sato F; Martinez NE; Stewart EC; Omura S; Alexander JS; Tsunoda I
    BMC Neurol; 2015 Oct; 15():219. PubMed ID: 26499989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
    Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
    Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative damage in multiple sclerosis lesions.
    Haider L; Fischer MT; Frischer JM; Bauer J; Höftberger R; Botond G; Esterbauer H; Binder CJ; Witztum JL; Lassmann H
    Brain; 2011 Jul; 134(Pt 7):1914-24. PubMed ID: 21653539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.